New research has found that there are genetic drivers of early onset Type 2 diabetes in British Asian people. A new study ...

We are addressing this need though generation, testing and publicising our new safe and effective peptide-based therapeutics for type 2 diabetes. We make use of naturally occurring peptide ... Islet ...

A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset ...

Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...

The research also identified a connection between higher heme iron intake and elevated levels of blood metabolic biomarkers associated with type 2 diabetes, such as C-peptide, triglycerides, and ...

(HealthDay News) — A eucaloric carbohydrate-restricted (CR) diet improves β-cell response to glucose in patients with type 2 diabetes (T2D), according to a study published online in the Journal of ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...